LPTX — Leap Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Leap Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	52.1	115	65.5	70.6	47.2
Net Total Receivables	0.073	1.19	2.1	0.771	0.704
Prepaid Expenses
Total Current Assets	52.3	117	68	71.6	48
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.593	0.495	0.689	0.262	0.262
Other Long Term Assets
Total Assets	54.4	118	70.4	72.8	49.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	7.37	9.99	11.2	12.7	14.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	7.72	10	11.5	12.7	14.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	46.7	108	58.9	60.1	35
Total Liabilities & Shareholders' Equity	54.4	118	70.4	72.8	49.1
Total Common Shares Outstanding